Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study.
- DOI
- 10.1055/s-0043-1774403
- Published
- 2024 Jan
- Container
- South Asian journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1055/s-0043-1774403,
title = {Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study.},
author = {Kasliwal S and K R and Reddy P and Maharaj N and M G and Adhav A and Harsh K and Madnoorkar N and Diwan A and Gupta M and Patel G and J SB and Dvorkin MV},
year = {2024},
journal = {South Asian journal of cancer},
doi = {10.1055/s-0043-1774403},
url = {https://doi.org/10.1055/s-0043-1774403}
}RIS
TY - JOUR TI - Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study. AU - Kasliwal S AU - K R AU - Reddy P AU - Maharaj N AU - M G AU - Adhav A AU - Harsh K AU - Madnoorkar N AU - Diwan A AU - Gupta M AU - Patel G AU - J SB AU - Dvorkin MV PY - 2024 JO - South Asian journal of cancer DO - 10.1055/s-0043-1774403 UR - https://doi.org/10.1055/s-0043-1774403 ER -
APA
S, K., R, K., P, R., N, M., G, M., A, A., K, H., N, M., A, D., M, G., G, P., SB, J., & MV, D. (2024). Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study.. South Asian journal of cancer. https://doi.org/10.1055/s-0043-1774403
Source records
- pubmed · retrieved 2026-09-27T16:29:31.807Z